» Articles » PMID: 22080425

Signs and Symptoms Predicting Influenza in Children: a Matched Case-control Analysis of Prospectively Collected Clinical Data

Overview
Publisher Springer
Date 2011 Nov 15
PMID 22080425
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to determine whether there are signs or symptoms that could help clinicians to distinguish between influenza and other respiratory infections. The clinical data for this matched case-control analysis were derived from a 2-year prospective cohort study of respiratory infections among children aged≤13 years. At any signs of respiratory infection, the children were examined and nasal swabs were obtained for virologic analyses. Cases were 353 children with laboratory-confirmed influenza and controls were 353 children with respiratory symptoms who tested negative for influenza. Cases and controls were matched for gender, age, and timing of the visit. In the multivariate conditional logistic regression analyses, fever was the only sign that independently predicted influenza virus infection, with odds ratios ranging from 13.55 (95% confidence interval [CI], 6.90-26.63) to 50.10 (95% CI, 16.25-154.45), depending on the degree of fever. In all analyses, the predictive capability of fever increased with incremental elevations in the child's temperature. The likelihood ratio of fever≥40.0°C in predicting influenza was 6.00 (95% CI, 2.80-12.96). Among unselected children seen as outpatients during influenza outbreaks, fever is the only reliable predictor of influenza virus infection. The optimal use of influenza-specific antiviral drugs in children may require virologic confirmation.

Citing Articles

SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort.

Dietz E, Pritchard E, Pouwels K, Ehsaan M, Blake J, Gaughan C BMC Med. 2024; 22(1):143.

PMID: 38532381 PMC: 10964495. DOI: 10.1186/s12916-024-03351-w.


RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial.

Yang S, Xie Y, Wang L BMC Complement Med Ther. 2023; 23(1):255.

PMID: 37474974 PMC: 10357598. DOI: 10.1186/s12906-023-04037-1.


Taiwanese Guidelines for Molecular Point-of-Care Testing for Influenza in Emergency Medicine From the New Diagnostic Technology Team of the Taiwan Society of Emergency Medicine.

Lee C, Liu Y J Acute Med. 2023; 13(2):47-57.

PMID: 37465825 PMC: 10351401. DOI: 10.6705/j.jacme.202306_13(2).0001.


Vital sign predictors of severe influenza among children in an emergent care setting.

Rao S, Moss A, Lamb M, Innis B, Asturias E PLoS One. 2022; 17(8):e0272029.

PMID: 35960719 PMC: 9374253. DOI: 10.1371/journal.pone.0272029.


Effect of Point-of-Care Testing for Respiratory Pathogens on Antibiotic Use in Children: A Randomized Clinical Trial.

Mattila S, Paalanne N, Honkila M, Pokka T, Tapiainen T JAMA Netw Open. 2022; 5(6):e2216162.

PMID: 35679047 PMC: 9185185. DOI: 10.1001/jamanetworkopen.2022.16162.


References
1.
Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Heikkinen T . Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age. Eur J Clin Microbiol Infect Dis. 2010; 30(3):387-92. DOI: 10.1007/s10096-010-1098-5. View

2.
Uyeki T, Prasad R, Vukotich C, Stebbins S, Rinaldo C, Ferng Y . Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis. 2009; 48(9):e89-92. DOI: 10.1086/597828. View

3.
Jhung M, Swerdlow D, Olsen S, Jernigan D, Biggerstaff M, Kamimoto L . Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis. 2011; 52 Suppl 1:S13-26. DOI: 10.1093/cid/ciq008. View

4.
Whitley R, Hayden F, Reisinger K, Young N, Dutkowski R, Ipe D . Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001; 20(2):127-33. DOI: 10.1097/00006454-200102000-00002. View

5.
Izurieta H, Thompson W, Kramarz P, Shay D, Davis R, DeStefano F . Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000; 342(4):232-9. DOI: 10.1056/NEJM200001273420402. View